Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Apple plans to shift part of its Mac Mini desktop production to a Foxconn facility in north Houston later this year. The company says Asian production will continue as the U.S. line ramps up. The move follows a broader U.S. investment pledge made last August and comes amid prior tariff threats and a mixed record on delivering new domestic manufactu…
Joseph Adamo, Chief Accounting Officer of Genco Shipping & Trading Limited, sold 6,340 shares on February 23, 2026, for about $150,067 and received 14,087 shares from vested restricted stock units the same day. Separately, Diana Shipping Inc. has made a non-binding cash proposal to acquire Genco at $20.60 per share and holds roughly 14.8% of Genco’…
Genco Shipping & Trading Ltd.'s chairman, CEO and president John C. Wobensmith sold 39,244 shares of GNK common stock on February 23, 2026 for about $928,513 while simultaneously taking delivery of 78,486 shares from vested restricted stock units. Separately, Diana Shipping Inc. has submitted a non-binding cash proposal to buy Genco for $20.60 per …
China's mainland equities opened higher following the Lunar New Year holiday as relief on U.S. trade tariffs and government-released holiday consumption data supported a broad advance. Export-focused names rose on prospects of reduced levies after a U.S. court ruling, while domestic retailers and travel-linked firms were bolstered by robust holiday…
Genco Shipping & Trading Ltd.'s Chief Financial Officer, Peter George Allen, completed sales of common stock totaling 13,315 shares for $315,005 on February 23, 2026, while also acquiring shares through option exercises and RSU vesting. The same day, Genco's board declined Diana Shipping Inc.'s attempt to nominate six director candidates as part of…
Genco Shipping & Trading Ltd.'s Chief Commercial Officer Jesper Christensen sold 18,450 shares of company stock on February 23, 2026 for roughly $436,527 while also receiving 38,438 shares through restricted stock unit vesting. The transaction coincides with a broader corporate dispute after Genco rejected Diana Shipping Inc.'s board nomination eff…
Gold prices eased in Asian trade after a four-session advance and a three-week peak, as investors booked profits and the dollar firmed. Spot gold fell 1.1% to $5,172.42 per ounce by 21:20 ET (02:20 GMT), while U.S. gold futures dropped 0.6% to $5,193.44/oz. The retreat followed a 2.5% jump in the previous session amid revived concerns over U.S. tra…
Gold reversed an earlier three-week high and fell as the U.S. dollar strengthened, a move that made dollar-priced bullion costlier for holders of other currencies. Comments on U.S. tariff policy and mixed signals from Federal Reserve officials added to market unease, while other precious metals and Asian equities also moved lower.
Ardelyx director David Mott reported a purchase of 333,333 shares on February 20, 2026, at a weighted average price of $5.839 per share, representing a total outlay of $1,946,331. The acquisition leaves Mott with 3,302,918 shares outright. The transaction occurred amid a recent near-15% slide in the stock and follows corporate updates including rev…
A U.S. Chemical Safety and Hazard Investigation Board report attributes a fatal hydrogen sulfide release at Pemex’s Deer Park, Texas, refinery to the absence of a standardized system for identifying equipment to be opened for work. The October 10, 2024 incident released about 27,000 pounds of hydrogen sulfide, killed two workers, prompted shelter-i…
Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy sold 5,000 shares of common stock on February 18, 2026, for $118,200 under a pre-arranged Rule 10b5-1 plan and simultaneously exercised options to acquire 5,000 shares at $1.53. The move comes amid recent analyst coverage, an FDA investigational device exemption approval for a cardiac …
John E. Bishop, Ardelyx's Chief Technical Operations Officer, sold 3,179 shares on February 20, 2026, in an automated transaction to cover withholding taxes tied to restricted stock unit vesting. The sales generated $18,586 at prices between $5.7003 and $5.865. The trade arrives amid a near 15% decline in Ardelyx stock over the prior week, even as …
Ardelyx Senior Vice President and Chief Accounting Officer Joseph James Reilly sold 4,991 shares on February 20, 2026, to satisfy tax withholding tied to vested restricted stock units. The trades, executed under a pre-arranged plan, generated $29,180 and leave Reilly with 151,790 shares directly held. The moves come amid recent share-price weakness…
Avantor director Gregory T. Lucier purchased 50,000 shares of Avantor, Inc. common stock on February 19, 2026, in transactions totaling $458,000. The purchases occurred at prices between $9.06 and $9.25 per share, with an average execution price reported at $9.16. The buy comes while the stock trades close to its 52-week low and after fourth-quarte…
Laura A. Williams, Ardelyx's Chief Patient Officer and interim Chief Medical Officer, sold 8,176 shares of common stock on February 20, 2026, in two transactions to cover withholding taxes tied to the vesting of restricted stock units. The trades, executed at prices between $5.7138 and $5.865, totaled $47,803. After the sale Williams holds 436,082 …
Oil prices held near a near seven-month high on Tuesday as market participants monitored the resumption of U.S.-Iran nuclear talks, heightened tensions in the Middle East and uncertainty over U.S. trade policy. Brent and U.S. crude saw modest declines after a choppy session that pushed benchmarks to their highest levels in months.
Ardelyx Chief Financial Officer Susan Hohenleitner sold 2,033 shares of common stock on February 20, 2026 to satisfy withholding tax obligations tied to restricted stock units. The transactions totaled $11,886. The company also provided forward-looking product revenue guidance for fiscal 2026, initiated a Phase 3 IBSRELA study, and received a U.S. …
Mike Kelliher, Chief Business Officer of Ardelyx, sold 9,695 shares of the company's common stock on February 20, 2026, in three transactions totaling $56,099 to satisfy withholding tax obligations tied to vested restricted stock units. The share price during those trades ranged from $5.705 to $5.865; the stock is trading at $5.75 and has fallen ne…
On February 20, 2026, Brady James Parker, Chief Human Resources Officer at Ardelyx, Inc. (NASDAQ: ARDX), sold 2,543 shares of common stock in two transactions to satisfy withholding tax obligations tied to vested restricted stock units. The trades totaled $14,867. The company concurrently reported several operational and regulatory developments, in…
The dollar softened as Asian markets resumed trading following holidays, with renewed uncertainty around U.S. tariff policy weighing on global trade prospects. Market participants parsed Supreme Court pushback on emergency tariffs, fresh presidential threats to raise duties, reports of U.S. rate checks in currency markets and signals from Federal R…
A senior U.S. administration official said DeepSeek trained its soon-to-be-released AI model on Nvidia's most advanced Blackwell chips, a development that may run afoul of U.S. export controls that bar sales of such chips to China. The company may strip technical indicators revealing American hardware use, and separate accusations by Anthropic clai…
Biodesix Chief Financial Officer Robin Harper Cowie sold 535 shares of company stock on February 23, 2026, for roughly $6,834, at a weighted average price of $12.7756. The transaction followed an options exercise on February 20, 2026, that yielded 1,469 shares via restricted stock units. The stock has risen 87.79% year-to-date even as the company w…
Kieran O’Kane, Chief Commercial Officer at Biodesix Inc. (NASDAQ: BDSX), sold 535 shares on Feb. 23, 2026 to cover tax obligations tied to recently vested restricted stock units. The transactions follow an option exercise on Feb. 20, 2026 that converted 1,469 RSUs into shares. Biodesix reported preliminary 2025 results showing revenue growth and EB…
Biodesix INC Chief Development Officer Gary Anthony Pestano sold 556 shares on February 23, 2026, for roughly $7,103 at a weighted average price of $12.7756. The transaction occurred as the stock traded close to an InvestingPro Fair Value of $13.12 and after preliminary results showed revenue growth and EBITDA profitability for 2025. Pestano had ex…
U.S. equity futures ticked higher Monday evening following a day of steep declines on Wall Street as uncertainty over new tariffs and anxieties about AI-related disruption in software pressured markets. Additional volatility stemmed from legal and geopolitical questions, including FedEx's suit seeking tariff refunds after a Supreme Court ruling and…
